1) Cat. No.: TRC-G601510; 2) Chemical Name: GDC-0941; 3) CAS No.: 957054-30-7; 4) Mol. Formula:  C23H27N7O3S2; 5) Mol. Weight: 513.64; 6) Packing Size: 5mg / 10mg; 7) Appearence: ; 8) Application Notes: GDC-0941 is a potent and selective oral inhibitor of the class I PI3K. GDC-0941 demonstrated broad spectrum of activity in breast, ovarian, lung, and prostate cancer models. Studies has also shown GDC-0941 may enhance anti-tumor activity of Docetaxel (D494420) in human breast cancer models. ; 9) Synonym: 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidine; 4-[2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)piperazin-1-yl]methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine; GDC 0941; GDC 941; GNE 0941; Pictilisib; Pictrelisib ; 10) Solubility: ; 11) Storage condition: ; 12) References: Jeffrey J.W., et al.: Clinical. Cancer. Rsch., 10, 1078 (2012); Murray, J.M., et al.: J. Medn. Chem., 55, 7686 (2012);